El tampón de lisis celular II es un tampón de lisis de alta calidad listo para su uso y adecuadoMás información
Have Questions?
Número de catálogo
Cantidad
FNN0021
100 mL
Número de catálogo FNN0021
Precio (EUR)
203,00
Each
-
Añadir al carro de la compra
Cantidad:
100 mL
Precio (EUR)
203,00
Each
Añadir al carro de la compra
Ask our AI about this Product
El tampón de lisis celular II es un tampón de lisis de alta calidad listo para su uso y adecuado para la preparación de extractos celulares para aplicaciones ELISA, Western blot e inmunoensayos de gránulos de anticuerpos (Luminex). El tampón se utiliza para la extracción total de proteínas y utiliza lisis basada en detergente, eliminando la necesidad de una interrupción mecánica celular. La formulación ayuda a retener la estructura y función de las proteínas necesarias para los ensayos enzimáticos o los inmunoensayos.
Formulación del tampón: 50 mM de Tris, pH 7,4, 250 mM de NaCl, 5 mM de EDTA, 50 mM de NaF, 1 mM de Na3VO4, 1 % de detergente, 0,02 % de NaN3
Este tampón de lisis celular no contiene inhibidores de proteasa y debe suplementarse con 1 mM de PMSF y cóctel inhibidor de proteasa justo antes de su uso.
Have questions about this product? Ask our AI assisted search.
Generating response
This is an AI-powered search and may not always get things right. You can help us make it better with a thumbs up or down on individual answers or by selecting the “Give feedback" button. Your search history and customer login information may be retained by Thermo Fisher and processed in accordance with our
Privacy Notice.
Los clientes que vieron este artículo también vieron
Search citations by name, author, journal title or abstract text
Buscar
Citations & References
Abstract
Cleavage of hyaluronan is impaired in aged dermal wounds.
Authors:Reed MJ, Damodarasamy M, Chan CK, Johnson MN, Wight TN, Vernon RB,
Journal:Matrix Biol
PubMed ID:23022999
'Changes in extracellular matrix (ECM) are one of many components that contribute to impaired wound healing in aging. This study examined the effect of age on the glycosaminoglycan hyaluronan (HA) in normal and wounded dermis from young (4-6 month-old) and aged (22-24 month-old) mice. HA content and size were similar ... More
Thyroid hormone controls the gene expression of HSV-1 LAT and ICP0 in neuronal cells.
'Various factors/pathways including hormonal regulation have been suggested to control herpes simplex virus type 1 (HSV-1) latency and reactivation. Our computer analysis identified a DNA repeat containing thyroid hormone-responsive elements (TRE) in the regulatory region of HSV-1 latency-associated transcript (LAT). Thyroid hormone (triiodothyronine, T(3)) functions via its receptor TR (thyroid ... More
miRNA-214 is related to invasiveness of human non-small cell lung cancer and directly regulates alpha protein kinase 2 expression.
Authors:Salim H, Arvanitis A, de Petris L, Kanter L, Hååg P, Zovko A, Özata DM, Lui WO, Lundholm L, Zhivotovsky B, Lewensohn R, Viktorsson K,
Journal:
PubMed ID:23929716
'The prognosis of non-small cell lung cancer (NSCLC) is poor, since it has often metastasized to distant organs by the time of diagnosis. Therefore, biomarkers predicting metastasis are crucial. miRNAs play important roles in the regulation of different tumor cell processes, including metastasis. We recently showed that miRNA-214 is linked ... More
miR-205 expression promotes cell proliferation and migration of human cervical cancer cells.
Authors:Xie H, Zhao Y, Caramuta S, Larsson C, Lui WO,
Journal:PLoS One
PubMed ID:23056551
MicroRNAs (miRNAs) are short non-coding RNA regulators that control gene expression mainly through post-transcriptional silencing. We previously identified miR-205 in a signature for human cervical cancer using a deep sequencing approach. In this study, we confirmed that miR-205 expression was frequently higher in human cervical cancer than their matched normal ... More
A preclinical assessment of neural stem cells as delivery vehicles for anti-amyloid therapeutics.
Authors:Njie eG, Kantorovich S, Astary GW, Green C, Zheng T, Semple-Rowland SL, Steindler DA, Sarntinoranont M, Streit WJ, Borchelt DR,
Journal:PLoS One
PubMed ID:22496779
Transplantation of neural stems cells (NSCs) could be a useful means to deliver biologic therapeutics for late-stage Alzheimer's disease (AD). In this study, we conducted a small preclinical investigation of whether NSCs could be modified to express metalloproteinase 9 (MMP9), a secreted protease reported to degrade aggregated Aß peptides that ... More